Hi Kezzek. Are you saying that the RX cornerstone patent has expired for non payment of fees? Does this also mean that someone could now challenge the patents reinstatement?
Kind of looks like an iffy company if they can't rustle together enough money to keep current such an important assett. I wonder if they disclosed to all of their convertable debt holders that they let their patent lapse? I would have thought they would have been obliged to let them know. Also did they file an 8K to inform the market if their lapsed patent? Pretty material if you ask me.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.